Login

William Annett, CEO, OncoCyte Corp 00:00:00

Share On Facebook Share On Twitter

OncoCyte releases positive data on lung cancer diagnostic study

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Dispute Resolution Clauses in FIDIC Contracts | Tony Dymond - Partner of Debevoise & Plimpton LLP
00:00:00
Sean P. Cleary, M.D.
00:00:00
Craniofacial Treatment: When to Start Care - Samir Mardini, M.D. Facial Plastic Surgeon, Mayo clinic
00:10:00
Curso de Impacto: Herramientas para Entender y Fortalecer Equipos
00:10:00
Critical Elements Lithium: Rose Project and Exploration Update
00:10:00
Musgrave Minerals: Advancing High-Grade Gold Discoveries in Western Australia
00:10:00
Becoming a Fortune 500 CEO: Brent Saunders on Strategy, Success, and Scaling in Big Pharma | Brent Saunder , CEO, Bausch + Lomb corp.
00:10:00
Challenger Exploration: Advancing High-Grade Gold Projects in Argentina and Ecuador
00:10:00
"Unveiling Litigation Finance: Cesar Bello's Insights on Investment Strategies and Risk Management at Corbin Capital Partners"
00:10:00
Unlocking Value in Ghana: New Core Gold's Journey and Future Prospects
00:10:00
CEO of Airgain Jacob Suen Participates in the Big Biz Show to Talk About the Craft of Wireless Simplification | Jacob Suen, President and Chief Executive Officer, Airgain Inc AIRG:NAQ
00:10:00
Top 5 Reasons to Register for the ArcGIS Pro Migration Course

© 2026 Nehu